MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$77,090
Unit: Dollar
Positive Cash Flow Breakdown
    • Derivative liability charged to ...
    • Change in fair value of derivati...
    • Proceeds from notes payable
    • Others
Negative Cash Flow Breakdown
    • Net loss from continuing operati...
    • Repayments on notes payable
    • Accounts payable
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss from continuing operations
-304,757
-521,114
-521,638
-
Loss on debt extinguishment
-
-
-
-32,347
Stock-based compensation
0
0
218,131
112,682
Amortization of debt discounts
23,751
23,494
15,926
2,132
Default penalties on notes payable charged to interest expense
-5,000
44,765
-
-
Net cash provided by operating activities from discontinued operations
-
-
-
0
Derivative liability charged to interest expense upon note default
100,640
-
-
-
Gain on sale of subsidiary assets
-
-
-
0
Change in fair value of derivative liabilities
-54,295
-
-
-
Net loss from continuing operations
-
-
-
-558,415
Deferred offering costs charged to expense
0
253,556
-
-
Depreciation expense
3,718
3,719
2,023
3,235
Amortization of right-of-use asset
6,678
9,849
9,653
30,826
Other current assets
-
-
-
-13,596
Prepaids and other current assets
-4,005
-4,005
-8,380
-
Accounts payable
-8,731
83,441
74,323
-30,946
Accrued expenses
40,118
32,463
23,679
39,992
Accrued expenses related parties
40,035
25,265
29,174
70,561
Net cash (used in) operating activities from continuing operations
-
-
-
-315,063
Lease liability
-6,842
-10,097
-9,899
-9,707
Net cash used in operating activities
-52,090
-50,654
-150,248
-315,063
Net cash (used) in investing activities from discontinued operations
-
-
-
0
Proceeds from sale of series d preferred shares and warrants, net of fees
0
0
57,484
-
Proceeds from sale of subsidiary net assets
-
-
-
0
Proceeds from convertible notes payable
5,000
150,000
-
63,000
Purchase of fixed assets
-
-
-
31,236
Payments of deferred offering costs
-
-
-
-16,289
Net cash (used) in investing activities from continuing operations
-
-
-
-31,236
Proceeds from sales of series d preferred shares
-
-
-
76,296
Net cash (used) in investing activities
-
-
-
-31,236
Repayments on convertible notes
-
-
-
0
Proceeds from sales of series c preferred shares
-
-
-
0
Net cash used in financing activities from discontinued operations
-
-
-
0
Proceeds from notes payable
50,000
5,000
97,500
81,640
Net Cash Provided By Used In Financing Activities Continuing Operations
-
-
-
237,225
Repayments on notes payable
80,000
65,000
-
0
Net cash provided by financing activities
-25,000
90,000
154,984
237,225
Net increase (decrease) in cash
-77,090
39,346
4,736
-109,074
Cash beginning
42,854
42,854
38,118
91,166
Cash ending
5,110
82,200
42,854
38,118
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net increase(decrease) in cash-$77,090 (-237.60%↓ Y/Y)Derivative liabilitycharged to interest...$100,640 Change in fair value ofderivative liabilities-$54,295 Accrued expenses$40,118 (-28.75%↓ Y/Y)Accrued expenses related parties$40,035 (17.83%↑ Y/Y)Amortization of debtdiscounts$23,751 Amortization of right-of-useasset$6,678 (-68.74%↓ Y/Y)Prepaids and othercurrent assets-$4,005 Depreciation expense$3,718 (-50.97%↓ Y/Y)Proceeds from notespayable$50,000 (-56.75%↓ Y/Y)Proceeds fromconvertible notes payable$5,000 (-96.15%↓ Y/Y)Net cash used inoperating activities-$52,090 (19.75%↑ Y/Y)Net cash provided byfinancing activities-$25,000 (-120.38%↓ Y/Y)Canceled cashflow$273,240 Canceled cashflow$55,000 Net loss fromcontinuing operations-$304,757 (88.02%↑ Y/Y)Repayments on notes payable$80,000 Accounts payable-$8,731 (-102.18%↓ Y/Y)Lease liability-$6,842 (74.39%↑ Y/Y)Default penalties onnotes payable charged...-$5,000

Hypha Labs, Inc. (FUNI)

Hypha Labs, Inc. (FUNI)